白细胞介素10检测对乳腺癌患者预后的评估价值

The valuation value of interleukin-10 for the prognosis of breast cancer patients

目的:探究白细胞介素10(IL-10)检测对乳腺癌患者预后的评估价值。方法:2018年8月-2019年5月收治乳腺癌患者86例,根据化疗疗效分为有效组50例和无效组36例。比较两组患者化疗前后血清IL-10水平。结果:有效组化疗后血清IL-10水平低于无效组,差异有统计学意义(P<0.05)。结论:血清IL-10检测对乳腺癌患者预后的评估具有一定价值,降低血清IL-10水平可能改善预后效果。

Objective:To explore the valuation value of interleukin-10 for the prognosis of breast cancer patients.Methods:From August 2018 to May 2019,86 breast cancer patients were selected.According to the chemotherapy effect,they were divided into the effective group(50 cases)and the ineffective group(36 cases).We compared the serum IL-10 levels of the two groups before and after treatment.Results:In the effective group,the level of serum IL-10 after chemotherapy was lower than that in the ineffective group,the difference was statistically significant(P<0.05).Conclusion:The detection of serum IL-10 has a certain value in the evaluation of prognosis of breast cancer patients,lowering the level of serum IL-10 may improve the prognosis.